Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.627,70
0,22%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM) Taxus Cardium Pharmaceuticals Group Inc (CE) (CRXM) Notizie

CRXM

Taxus Cardium Pharmaceut... (CE) (CRXM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CRXM
DataOraFonteTitoloSimboloCompagnia
14/04/202212:10Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
30/03/202223:27Edgar (US Regulatory)Annual Report (10-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
27/10/202115:17Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
09/08/202122:59Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
28/07/202123:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
18/03/202119:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
01/03/202122:52Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
01/03/202122:47Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
22/12/202021:24Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
04/12/201821:22Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
04/01/201816:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
30/03/201718:49Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
28/05/201512:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
27/03/201523:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CRXMTaxus Cardium Pharmaceuticals Group Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:CRXM

La tua Cronologia

NASDAQI
NETLXT
Fundamental Income Net L...
TSX
MDA
MDA Space
BIT
F12035
Vontobel Financial Produ...
TG
YXS
Sany Heavy Equipment
NASDAQ
OXSQ
Oxford Square Capital
NASDAQ
FFUKGX
Diversified High Income ...
COIN
BOSONUST
Boson Token
COIN
EXNGBP
NASDAQ
AAZEXXX
Barclays Bank Plc Autoca...
NYSE
ZTAX
X-Square Series
NASDAQI
FN25
First North 25
EU
INCEC
Lyxor CEC Inav
USOTC
LIGA
LIG Assets (PK)
USOTC
PVGDF
Provenance Gold (QB)
LSE
J37
TG
G24
Scout24 SE NA ON
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network